PROCEPT BioRobotics Corporation
Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| PRCT.MX | PEN | HAE | BSX | ATEC | BBNX | |
|---|---|---|---|---|---|---|
| Market cap | 19.29B | 12.78B | 5.38B | 66.06B | 1.68B | 957.01M |
| P/E (TTM) | — | 79.7 | 57.1 | 18.5 | — | — |
| Forward P/E | — | 52.9 | 20.5 | 13.5 | 18.1 | -8.2 |
| Price/book | 3.1 | 8.3 | 6.4 | 2.6 | -137.5 | 3.1 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −73.56% | +28.69% | +130.25% | −56.11% | −30.70% | −16.40% |
| Today | +3.66% | +0.60% | −0.44% | +1.18% | +4.32% | +5.34% |
The closest companies by business and industry (Medical Devices). Prices may be delayed up to 20 min.
Latest news
All PRCT.MX news ›Analysts Are Bullish on Top Healthcare Stocks: Abbott Laboratories (ABT), PROCEPT BioRobotics (PRCT)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Abbott Laboratories (ABT), PROCEPT BioRobotics (PRCT) and Taysha Gene Therapies (TSHA) with bullish sentiments. TD Cowen analyst Josh Jennings…
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Stock Now Rated "Hold" by Wall Street Analysts
View Our Latest Stock Analysis on PRCT PROCEPT BioRobotics Corp. is a medical technology company focused on developing and commercializing robotic and image-guided systems for urologic procedures. The company's primary focus is benign…
California laboratory technologies company purchases Proscia
Pennsylvania Business Report - Home » News » California laboratory technologies company purchases Proscia California-based Agilent Technologies, an analytical and clinical laboratory technologies company, recently entered into a definitive…
Benjamin Schenk Appointed to Plaintiffs' Steering Committee in Landmark Chat GPT Product Liability Litigation
Oct 14, 2026, 13:30 ET San Diego Attorney Joins Leadership Team in California Coordinated Proceeding Against OpenAI Over Alleged AI Chatbot Harms SAN DIEGO, Oct. 14, 2026 /PRNewswire-PRWeb/ -- Benjamin Schenk, a partner with The Schenk Law…
PROCEPT BioRobotics® to Report Third Quarter 2026 Financial Results on November 4th, 2026
The Manila Times SAN JOSE, Calif., Oct. 12, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (the "Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in…
Agilent to buy pathology software maker Proscia for $240 million
Your Privacy is Important to us Opt out of the sale or sharing of personal information Agilent to buy pathology software maker Proscia for $240 million Privately held Proscia develops software that converts pathology slides into digital…
Pepkor $1.3 billion fintech deal should have faced shareholder vote, investor says
News business : Pepkor Holding Ltd.’s deal to merge its fintech arm with a rival business has upset some who were not allowed to vote on a transaction that marks a major shift in strategy for Africa’s biggest clothing retailer.
Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of Semtech Corporation (SMTC), Roblox Corporation (RBLX), Quantum Corporation (QMCO), and PROCEPT BioRobotics Corporation (PRCT)
SAN DIEGO, Oct. 09, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of current, long-term shareholders of Semtech Corporation (NASDAQ: SMTC), Roblox Corporation (NYSE: RBLX), Quantum Corporation…
PROCEPT BioRobotics (NASDAQ:PRCT) Upgraded at Barclays
PROCEPT BioRobotics (NASDAQ:PRCT - Get Free Report) was upgraded by equities research analysts at Barclays to a "strong-buy" rating in a research report issued on Tuesday, Zacks reports. Check Out Our Latest Stock Report on PROCEPT…
ClearPoint faces securities fraud probe after Huntington's drug trial data disappoints, stock drops 23%.
ClearPoint Neuro is under investigation by Pomerantz LLP for potential securities fraud following a press release by its partner uniQure, which revealed that a Huntington's disease treatment failed to meet key clinical goals. This news…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
-
stocktitan.net5
-
globenewswire.com3
-
marketbeat.com3
-
pluang.com2
-
theglobeandmail.com2
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 28 articles, not a forecast.